Get started
Markets Poland Stocks Health Technology Pharmaceuticals: Major

BIOMEDLUB BML

BMLGPW
BML
BIOMEDLUBGPW
See more on advanced chartSee more on advanced chart
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals

BML chart

Ideas

BIOMEDLUB BML
BML
, 1WLong
BML: BIOMEDLUB BML
Updated 

Raising sequence is evolving, (iii)/5 wave to occur now.

Antibody medicine move
BML
, 1DLong
BML: Antibody medicine move
Updated 

Biomedlub should soon announce that thier medicine for COVID-19 passed tests. We can see consolidation on chart.

BIOMED
BML
, 60Long
BML: BIOMED

Currently downtrend of BIOMED Price Targets: 14,50zzł - 0.618Fib and GANN support 12zł Support area Waiting for green signal from SMASRI96

BML BIOMEDLUB
BML
, 60Long
BML: BML BIOMEDLUB

5th wave to come...

BIOMEDLUB BML
BML
, 60Long
BML: BIOMEDLUB BML

(5) wave to go now.

Biomedlub BML
BML
, 60Long
BML: Biomedlub BML
Updated 

Another round to 18-20 PLN after today's correction.

BIOMED
BML
, 60Long
BML: BIOMED
Updated 

General correction in terms of price is over, we shall see rally to lower rectangle at least.

Cofniecie i do flagi. Najbliższy cel 17 PLN
BML
, 1D
BML: Cofniecie i do flagi. Najbliższy cel 17 PLN

Wejście do flagi po korekcyjnej fali Elliota. Możliwość tradowania w ramach flagi. Uwaga, pilnować wyjścia.

BIOMEDLUB BML
BML
, 240
BML: BIOMEDLUB BML
Updated 

.....................

Biomed
BML
, 60
BML: Biomed

How I see it now

Tirangle on Biomed
BML
, 1D
BML: Tirangle on Biomed

In my opinion it will break up, but comfirmation it's necessary

BIOMEDLUB
BML
, 240Long
BML: BIOMEDLUB

...................

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins}
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Biomed Lublin Wytwornia Surowic i Szczepionek SA engages in the manufacture of pharmaceutical products. It offers prescription and over-the-counter medicines, medical devices, and laboratory reagents. The company was founded on December 4, 1944 and is headquartered in Lublin, Poland.

News flow

More news